Mode
Text Size
Log in / Sign up
Phase 2 Completed N=217 Randomized Double-blind Treatment

Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo

Source: ClinicalTrials.gov NCT02046980 ↗
Enrolled (actual)
217
Serious AEs
0.0%
Results posted
Mar 2016
Primary outcomePrimary: Conversion in Direction of Nystagmus From Apogeotropic to Geotropic or Disappearance of Nystagmus — 51; 46; 38 participants — p=0.02839

Summary

To determine the short term therapeutic efficacies of Gufoni maneuver and mastoid oscillation in apogeotropic type of benign paroxysmal positional vertigo (BPPV) involving the horizontal semicircular canal (HC-BPPV), a randomized, prospective, sham-controlled study was conducted.

Outcome Measures

OutcomeResultp-value
PRIMARY
Conversion in Direction of Nystagmus From Apogeotropic to Geotropic or Disappearance of Nystagmus
51; 46; 38 0.02839 sig

Eligibility Criteria

Inclusion Criteria

  • history of vertigo associated with changes in head position
  • direction-changing horizontal nystagmus beating toward the uppermost ear (apogeotropic nystagmus) in both turning positions detected with Frenzel glasses or videoculography in the Head turning test
  • vertigo associated with the elicited nystagmus
  • symptom within 2 weeks
  • put one's signature on consent

Exclusion Criteria

  • patients with identifiable central nervous system disorders that could explain the positional vertigo and nystagmus
  • the patients with apogeotropic form which was transited from geotropic after previous therapeutic maneuvers
  • the patients who transited from apogeotropic from vertical canal BPPV during study
  • patients who had possible cause of secondary BPPV such as Meniere's disease, migraine or recent trauma history
  • patients whose affected ear cannot be identified
  • patients with multiple canal atypical positional nystagmus or who were treated previously with repositioning maneuvers were excluded.
  • patients with cervical or lumbar spine problem
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02046980). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search